Exploring the anti-aging combo for long-term health benefits: Metformin + Rybelsus

Metformin: Basic Information and Mechanisms

Metformin is a member of the biguanide class of drugs and has been used for more than 60 years, primarily for the treatment of type 2 diabetes. Because of its strong safety record and long clinical history, it is widely prescribed as a first-line medication.

Recently, however, metformin has attracted attention for more than its blood sugar–lowering properties. It is now being studied as a medication that may improve metabolism at the cellular level and potentially contribute to healthy aging.

Below, we review its basic profile and key mechanisms of action.

Metformin is attracting attention because it interacts directly with the cell’s energy and metabolic systems. Its main mechanisms can be grouped into three major axes.¹

• Activation of the “Longevity Gene” AMPK and Autophagy
  This is the core of much anti-aging research.Metformin activates AMPK, an enzyme that functions as the cell’s energy sensor. When AMPK is turned on, the body interprets this as a kind of mild “fasting” or “energy shortage” signal. In response, cells trigger autophagy, a self-cleaning process that breaks down old proteins and waste products.Through this mechanism, it is thought that damaged components inside cells are removed and cellular function is “reset” throughout the body.
• DNA Repair and Reduction of Oxidative Stress
  One major driver of aging is damage to DNA, the cell’s blueprint, together with oxidative stress often described as “rusting” of the body caused by reactive oxygen species.Metformin appears to have antioxidant properties and may help reduce oxidative stress, supporting the cell’s DNA repair systems. This combination could contribute to slower cellular aging over time.
• Improvement of Glucose Metabolism and Insulin Resistance
  Metformin reduces excess glucose production in the liver and increases glucose uptake in muscle tissue. As a result, the body can manage blood sugar with lower insulin levels.This reduces the burden on the pancreas and promotes a metabolic state that is less prone to weight gain and age-related metabolic decline.

Common Side Effects: Gastrointestinal Symptoms

About 20 to 30 percent of people experience digestive issues such as diarrhea, loose stools, nausea, or abdominal pain when they first start taking metformin.⁴

What can help:

• Taking the medication after meals rather than on an empty stomach
• Starting at a low dose (for example, 250 to 500 mg per day) and increasing gradually

These strategies can significantly reduce symptoms for many patients.

Rare but Serious Side Effect: Lactic Acidosis

Lactic acidosis is a very rare but serious complication in which lactic acid accumulates in the blood, making it more acidic. The risk rises under specific conditions, including:⁵

• Heavy alcohol consumption
• Dehydration from fever, diarrhea, or intensive exercise
• Reduced kidney function
• Significant liver dysfunction
• Serious cardiac or respiratory disease
• Before and after procedures that use iodinated contrast agents (such as CT scans)
• Advanced age
• Pregnancy

Because of this, kidney function and overall health status need to be checked carefully before starting metformin.

Long-Term Use: Points to Monitor

• Vitamin B12 deficiency: Long-term metformin use may reduce absorption of vitamin B12. Periodic blood tests are recommended to monitor for deficiency.

Who May Be a Candidate and Who Should Avoid It

Metformin is a prescription medication and should be used under a doctor’s supervision. In particular, kidney function must be evaluated before use.

People who should consider this treatment (in a self-pay/private practice setting)

• Those interested in extending their healthy lifespan based on available scientific data
• Those who want support in maintaining a less weight-prone body, in addition to diet and exercise
• Those who want to invest in long-term health while keeping costs manageable

People who should not use metformin

• People with significant kidney impairment (eGFR below 30: contraindicated; eGFR 30–60: requires cautious use)
• Those with severe liver dysfunction, heart failure, or respiratory disease
• Heavy alcohol users
• Pregnant women, breastfeeding women, or those who may be pregnant

Metformin is highly effective at supporting the metabolic foundation, but as noted, its weight loss effect alone is modest.

For people who hope to see visible changes in body shape and weight, a combination strategy that adds Rybelsus 3 mg is gaining attention.

• 1. Impact on Body Weight: Combination vs. Monotherapy
  When Rybelsus is used as a single agent, clinically significant weight loss often requires dose escalation. However, when combined with metformin, meaningful results have been reported even at low doses. According to overseas clinical data, combination therapy with metformin and Rybelsus produced about three times the weight loss effect compared with metformin alone. In some reports, this translated into an average reduction of around 6 kg over 16 weeks.⁶
  
  In simple terms:
  
• Metformin helps create a body that burns energy more efficiently
• Rybelsus helps accelerate weight loss and reduce calorie intake
• 2. Complementary Actions: Appetite Control in the Brain and Metabolic Support in Cells
  Metformin and Rybelsus work on different targets that complement each other.
  
• Metformin acts at the cellular level, including the mitochondria and DNA. It contributes to more efficient energy use and supports cellular repair processes such as autophagy.
• Rybelsus acts on the brain’s appetite centers, helping to reduce hunger and curb snacking. It may also help reduce brain inflammation and support concentration and emotional stability.
• By combining these mechanisms, taking metformin and Rybelsus together may create a metabolic environment that more effectively supports weight management and overall health.
• 3. Supporting “Aging Care,” DNA Repair, and Focus
  
  In many cases, higher doses of Rybelsus (7 to 14 mg) are used to achieve strong benefits, but these doses can increase the risk of side effects such as severe nausea. When Rybelsus is used on top of a metformin base, however, it may be possible to achieve adequate benefit at 3 mg, which is considered a relatively low and more tolerable dose.
  
  Potential advantages of this approach include:
• Lower side effect risk: reduced burden on the body
• Better continuity: easier to continue long term, which is important for preventing rebound weight gain
• That said, both medications influence blood sugar and the digestive system. Combining them without medical guidance can increase the risk of issues such as hypoglycemia or dehydration.
  
  *You should always consult a physician, confirm that there are no problems with kidney function or other conditions, and receive a proper prescription. In Japan, using these medications for weight loss is considered off-label and falls under self-pay medical care.

To benefit safely from metformin, it is important to understand the basic principles of how it is prescribed and taken.

• Low-Dose Start and Gradual Titration: Treatment usually begins with a low dose, such as 250 to 500 mg once daily, and the dose is gradually increased over several weeks to an effective range, for example 750 to 1500 mg, as long as side effects remain manageable.
• Timing with Meals:
  Clinical studies have examined metformin taken shortly before meals (about 10 minutes before) and after meals. In practice, taking metformin with food is often preferred to reduce gastrointestinal discomfort.
• “Sick Day” Rules:
  On days when you cannot eat properly due to fever, diarrhea, vomiting, or dehydration, doctors may recommend temporarily stopping metformin to reduce the risk of lactic acidosis.

Means of Acquisition:
Metformin is prescribed after a medical consultation at a healthcare facility.Self-directed use, such as personal importation, is not recommended. It can expose you to counterfeit products and delay appropriate responses to side effects.

Note on non-insurance clinics:
The uses of metformin discussed in this article, namely weight loss and anti-aging, are not approved indications in Japan. Metformin is officially approved only for type 2 diabetes and polycystic ovary syndrome (PCOS). Any use for cosmetic or general health purposes falls under self-pay medical care, meaning all costs are the patient’s responsibility and such use is not covered by Japan’s Pharmaceutical Side-effect Relief System in the event of adverse reactions. For these reasons, it is essential to carefully discuss potential benefits and risks with a qualified physician before considering metformin or metformin–Rybelsus combination therapy for off-label use.

1.Cell Metab. 2016;23(6):1060-1065.
2.N Engl J Med. 2002 Feb 7;346(6):393-403.
3.Lancet. 1998 Sep 12;352(9131):854-65.
4.Front Endocrinol (Lausanne). 2022 Sep 14:13:975912.
5.住友ファーマ株式会社 メトグルコ添付文書
6.Reprod Biol Endocrinol. 2025 Jul 26;23(1):108.